Showing results (161-170 of 169) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Plos Pathogens|July 21, 2023
Thrombin cleavage of the hepatitis E virus polyprotein at multiple conserved locations is required for genome replicationDanielle M Pierce, Frazer J T Buchanan, Fraser L Macrae, et al.Molecular Imaging and Biology|January 18, 2015
Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human StudyF Bretin, M A Bahri, C Bernard, et al.Journal of Wildlife Diseases|April 28, 2009
Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, CanadaR C Rosatte, D Donovan, J C Davies, et al.Journal of Wildlife Diseases|March 29, 2011
High-density baiting with ONRAB® rabies vaccine baits to control Arctic-variant rabies in striped skunks in Ontario, CanadaR C Rosatte, D Donovan, J C Davies, et al.Nature Medicine|July 17, 2007
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infectionMark J Walker, Andrew Hollands, Martina L Sanderson-Smith, et al.Journal of Wildlife Diseases|October 30, 2008
Prevalence of tetracycline and rabies virus antibody in raccoons, skunks, and foxes following aerial distribution of V-RG baits to control raccoon rabies in Ontario, CanadaR Rosatte, M Allan, P Bachmann, et al.The American Journal of Psychiatry|August 10, 2013
The hotel study: multimorbidity in a community sample living in marginal housingFidel Vila-Rodriguez, William J Panenka, Donna J Lang, et al.G3 (Bethesda, Md.)|June 19, 2023
The generation of the first chromosome-level de novo genome assembly and the development and validation of a 50K SNP array for the St. John River aquaculture strain of North American Atlantic salmonGuangtu Gao, Geoffrey C Waldbieser, Ramey C Youngblood, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2024
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancerT Van Gorp, D Cibula, W Lv, et al.Pageof 17